 Interleukin-13 Receptor alpha2 Subunit
"Interleukin-13 Receptor alpha2 Subunit" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An interleukin-13 receptor subunit that is closely-related to the INTERLEUKIN-13 RECEPTOR ALPHA1 SUBUNIT. The receptor is found as a monomeric protein and has been considered to be a decoy receptor for interleukin-13 due the fact that it lacks cytoplasmic signaling domains.
| Descriptor ID |
D053663
|
| MeSH Number(s) |
D12.776.543.750.705.852.420.600.300 D23.050.301.264.035.413 D23.101.100.110.413
|
| Concept/Terms |
Interleukin-13 Receptor alpha2 Subunit- Interleukin-13 Receptor alpha2 Subunit
- Interleukin 13 Receptor alpha2 Subunit
- CD213a2 Antigen
- Antigen, CD213a2
- CD213a2 Antigens
- Receptor, Interleukin-13 alpha2
- Interleukin-13 alpha2 Receptor
- alpha2 Receptor, Interleukin-13
- IL13Ralpha2
- Interleukin-13 Decoy Receptor
- Decoy Receptor, Interleukin-13
- Interleukin 13 Decoy Receptor
- Interleukin-13 Receptor alpha2
- Interleukin 13 Receptor alpha2
- Receptor alpha2, Interleukin-13
- Interleukin-13 Receptor alpha2 Chain
- Interleukin 13 Receptor alpha2 Chain
- Antigens, CD213a2
- IL-13 Receptor alpha2
- IL 13 Receptor alpha2
- Receptor alpha2, IL-13
|
Below are MeSH descriptors whose meaning is more general than "Interleukin-13 Receptor alpha2 Subunit".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Membrane Proteins [D12.776.543]
- Receptors, Cell Surface [D12.776.543.750]
- Receptors, Immunologic [D12.776.543.750.705]
- Receptors, Cytokine [D12.776.543.750.705.852]
- Receptors, Interleukin [D12.776.543.750.705.852.420]
- Receptors, Interleukin-13 [D12.776.543.750.705.852.420.600]
- Interleukin-13 Receptor alpha2 Subunit [D12.776.543.750.705.852.420.600.300]
- Biological Factors [D23]
- Antigens [D23.050]
- Antigens, Surface [D23.050.301]
- Antigens, Differentiation [D23.050.301.264]
- Antigens, CD [D23.050.301.264.035]
- Interleukin-13 Receptor alpha2 Subunit [D23.050.301.264.035.413]
- Biological Markers [D23.101]
- Antigens, Differentiation [D23.101.100]
- Antigens, CD [D23.101.100.110]
- Interleukin-13 Receptor alpha2 Subunit [D23.101.100.110.413]
Below are MeSH descriptors whose meaning is more specific than "Interleukin-13 Receptor alpha2 Subunit".
This graph shows the total number of publications written about "Interleukin-13 Receptor alpha2 Subunit" by people in UAMS Profiles by year, and whether "Interleukin-13 Receptor alpha2 Subunit" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2022 | 1 | 0 | 1 | | 2018 | 2 | 0 | 2 | | 2016 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Interleukin-13 Receptor alpha2 Subunit" by people in Profiles over the past ten years.
-
Brown CE, Rodriguez A, Palmer J, Ostberg JR, Naranjo A, Wagner JR, Aguilar B, Starr R, Weng L, Synold TW, Tran V, Wang S, Reik A, D'Apuzzo M, Ressler JA, Zhou Y, Mendel M, Gregory PD, Holmes MC, Tang WW, Forman SJ, Jensen MC, Badie B. Off-the-shelf, steroid-resistant, IL13Ra2-specific CAR T cells for treatment of glioblastoma. Neuro Oncol. 2022 08 01; 24(8):1318-1330.
-
Joseph SK, Samaha H, Bielamowicz K, Ahmed N. Response to the comment on "Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma" by Bielamowicz et al. Neuro Oncol. 2018 06 18; 20(7):1004-1005.
-
Bielamowicz K, Fousek K, Byrd TT, Samaha H, Mukherjee M, Aware N, Wu MF, Orange JS, Sumazin P, Man TK, Joseph SK, Hegde M, Ahmed N. Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma. Neuro Oncol. 2018 03 27; 20(4):506-518.
-
Hegde M, Mukherjee M, Grada Z, Pignata A, Landi D, Navai SA, Wakefield A, Fousek K, Bielamowicz K, Chow KK, Brawley VS, Byrd TT, Krebs S, Gottschalk S, Wels WS, Baker ML, Dotti G, Mamonkin M, Brenner MK, Orange JS, Ahmed N. Tandem CAR T cells targeting HER2 and IL13Ra2 mitigate tumor antigen escape. J Clin Invest. 2016 08 01; 126(8):3036-52.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|